Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Lung Tissue Differentially Mitigate Lung and Distal Organ Damage in Experimental Acute Respiratory Distress Syndrome

Critical Care Medicine

Volumn 46, Issue 2, 2018, Pages E132-E140

  Silva, Johnatas D ^a   Lopes Pachec, Miquéias ^a   Paz, Ana H R ^b   Cruz, Fernanda F ^a   Melo, Elga B ^b   De Oliveira, Milena V ^a   Xisto, Débora G ^a   Capelozzi, Vera L ^c   Morales, Marcelo M ^a   Pelosi, Paolo ^d   Cirne Lim, Elizabeth ^b   Rocco, Patricia R M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Acute respiratory distress syndrome; Growth factors; lung inflammation; mesenchymal stem cells; tissue remodeling

Indexed keywords

ALPHA5 INTEGRIN; BETA1 INTEGRIN; COLLAGEN; GROWTH FACTOR; INTERLEUKIN 1BETA; KERATINOCYTE DERIVED CHEMOKINE; KERATINOCYTE GROWTH FACTOR; PROCASPASE 3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ADIPOSE TISSUE; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW; CELL COUNT; CELL DAMAGE; CELL DEGENERATION; CELL ISOLATION; CONTROLLED STUDY; ELASTIC FIBER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOLOGY; INFLAMMATION; INFLAMMATORY CELL; LIVER FATTY DEGENERATION; LUNG FUNCTION; LUNG INJURY; LUNG MECHANICS; LUNG PARENCHYMA; MALE; MESENCHYMAL STEM CELL; MICROPHOTOGRAPHY; MORPHOMETRY; MRNA EXPRESSION LEVEL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; PNEUMONIA; RAT; RAW 264.7 CELL LINE; TISSUE REMODELING; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME; TUNEL ASSAY; ANIMAL; BONE MARROW CELL; COMPLICATION; CYTOLOGY; DISEASE MODEL; KIDNEY DISEASE; LIVER DISEASE; LUNG; LUNG DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; RANDOMIZATION; WISTAR RAT;

ADIPOSE TISSUE; ANIMALS; BONE MARROW CELLS; DISEASE MODELS, ANIMAL; FEMALE; KIDNEY DISEASES; LIVER DISEASES; LUNG; LUNG DISEASES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; RANDOM ALLOCATION; RATS; RATS, WISTAR; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 85047728987     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002833     Document Type: Article

References (51)

1. Bellani G, Pham T, Laffey J; LUNG-SAFE Investigators; ESICM Trials Group: Incidence of acute respiratory distress syndrome-reply. JAMA 2016;316:347
2. Buregeya E, Fowler RA, Talmor DS, et al: Acute respiratory distress syndrome in the global context. Glob Heart 2014;9:289-295
3. Tonelli AR, Zein J, Adams J, et al: Effects of interventions on survival in acute respiratory distress syndrome: An umbrella review of 159 published randomized trials and 29 meta-analyses. Intensive Care Med 2014;40:769-787
4. Maron-Gutierrez T, Silva JD, Asensi KD, et al: Effects of mesenchymal stem cell therapy on the time course of pulmonary remodeling depend on the etiology of lung injury in mice. Crit Care Med 2013;41:e319-e333
5. Shin L, Peterson DA: Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells. Stem Cells Transl Med 2013;2:33-42
6. Chen J, Li Y, Hao H, et al: Mesenchymal stem cell conditioned medium promotes proliferation and migration of alveolar epithelial cells under septic conditions in vitro via the JNK-P38 signaling pathway. Cell Physiol Biochem 2015;37:1830-1846
7. Baraniak PR, McDevitt TC: Stem cell paracrine actions and tissue regeneration. Regen Med 2010;5:121-143
8. Walter J, Ware LB, Matthay MA: Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. Lancet Respir Med 2014;2:1016-1026
9. Hayes M, Curley GF, Masterson C, et al: Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injury. Intensive Care Med Exp 2015;3:29
10. Zheng G, Huang L, Tong H, et al: Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: A randomized, placebo-controlled pilot study. Respir Res 2014;15:39
11. Wilson JG, Liu KD, Zhuo H, et al: Mesenchymal stem (stromal) cells for treatment of ARDS: A phase 1 clinical trial. Lancet Respir Med 2015;3:24-32
12. Antunes MA, Abreu SC, Cruz FF, et al: Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema. Respir Res 2014;15:118
13. Boxall SA, Jones E: Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int 2012;2012:975871
14. Saldiva PH, Zin WA, Santos RL, et al: Alveolar pressure measurement in open-chest rats. J Appl Physiol (1985) 1992;72:302-306
15. Maron-Gutierrez T, Silva JD, Cruz FF, et al: Insult-dependent effect of bone marrow cell therapy on inflammatory response in a murine model of extrapulmonary acute respiratory distress syndrome. Stem Cell Res Ther 2013;4:123
16. Silva JD, Paredes BD, Araújo IM, et al: Effects of bone marrowderived mononuclear cells from healthy or acute respiratory distress syndrome donors on recipient lung-injured mice. Crit Care Med 2014;42:e510-e524
17. de Oliveira GP, Silva JD, de Araújo CC, et al: Intravenous glutamine administration reduces lung and distal organ injury in malnourished rats with sepsis. Shock 2014;41:222-232
18. Cruz FF, Horta LF, Maia Lde A, et al: Dasatinib reduces lung inflammation and fibrosis in acute experimental silicosis. PLoS One 2016;11:e0147005
19. Ostanin AA, Petrovskii YL, Shevela EY, et al: Multiplex analysis of cytokines, chemokines, growth factors, MMP-9 and TIMP-1 produced by human bone marrow, adipose tissue, and placental mesenchymal stromal cells. Bull Exp Biol Med 2011;151:133-141
20. Lathrop MJ, Brooks EM, Bonenfant NR, et al: Mesenchymal stromal cells mediate Aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the Th17 signaling pathway. Stem Cells Transl Med 2014;3:194-205
21. Cruz FF, Borg ZD, Goodwin M, et al: Systemic administration of human bone marrow-derived mesenchymal stromal cell extracellular vesicles ameliorates aspergillus hyphal extract-induced allergic airway inflammation in immunocompetent mice. Stem Cells Transl Med 2015;4:1302-1316
22. Cruz FF, Weiss DJ, Rocco PR: Prospects and progress in cell therapy for acute respiratory distress syndrome. Expert Opin Biol Ther 2016;16:1353-1360
23. Simonson OE, Mougiakakos D, Heldring N, et al: In vivo effects of mesenchymal stromal cells in two patients with severe acute respiratory distress syndrome. Stem Cells Transl Med 2015;4:1199-1213
24. Mei SH, Haitsma JJ, Dos Santos CC, et al: Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010;182:1047-1057
25. McAuley DF, Curley GF, Hamid UI, et al: Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am J Physiol Lung Cell Mol Physiol 2014;306:L809-L815
26. Chan MC, Kuok DI, Leung CY, et al: Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo. Proc Natl Acad Sci U S A 2016;113:3621-3626
27. McIntyre LA, Moher D, Fergusson DA, et al; Canadian Critical Care Translational Biology Group: Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: A systematic review. PLoS One 2016;11:e0147170
28. Fraser JK, Wulur I, Alfonso Z, et al: Fat tissue: An underappreciated source of stem cells for biotechnology. Trends Biotechnol 2006;24:150-154
29. Peng L, Jia Z, Yin X, et al: Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cells Dev 2008;17:761-773
30. Wagner W, Wein F, Seckinger A, et al: Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005;33:1402-1416
31. Zanata F, Shaik S, Devireddy RV, et al: Cryopreserved adipose tissuederived stromal/stem cells: Potential for applications in clinic and therapy. Adv Exp Med Biol 2016;951:137-146
32. Mahmoudifar N, Doran PM: Mesenchymal Stem cells derived from human adipose tissue. Methods Mol Biol 2015;1340:53-64
33. Baer PC, Geiger H: Adipose-derived mesenchymal stromal/stem cells: Tissue localization, characterization, and heterogeneity. Stem Cells Int 2012;2012:812693
34. Girdlestone J: Mesenchymal stromal cells with enhanced therapeutic properties. Immunotherapy 2016;8:1405-1416
35. Banas A, Teratani T, Yamamoto Y, et al: IFATS collection: In vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 2008;26:2705-2712
36. Martínez-González I, Roca O, Masclans JR, et al: Human mesenchymal stem cells overexpressing the IL-33 antagonist soluble IL-1 receptor-like-1 attenuate endotoxin-induced acute lung injury. Am J Respir Cell Mol Biol 2013;49:552-562
37. Chien MH, Bien MY, Ku CC, et al: Systemic human orbital fat-derived stem/stromal cell transplantation ameliorates acute inflammation in lipopolysaccharide-induced acute lung injury. Crit Care Med 2012;40:1245-1253
38. Sun CK, Yen CH, Lin YC, et al: Autologous transplantation of adiposederived mesenchymal stem cells markedly reduced acute ischemiareperfusion lung injury in a rodent model. J Transl Med 2011;9:118
39. Zhang S, Danchuk SD, Imhof KM, et al: Comparison of the therapeutic effects of human and mouse adipose-derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury. Stem Cell Res Ther 2013;4:13
40. Mao YX, Xu JF, Seeley EJ, et al: Adipose tissue-derived mesenchymal stem cells attenuate pulmonary infection caused by pseudomonas aeruginosa via inhibiting overproduction of prostaglandin E2. Stem Cells 2015;33:2331-2342
41. Hoffman AM, Paxson JA, Mazan MR, et al: Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lung. Stem Cells Dev 2011;20:1779-1792
42. Ingenito EP, Tsai L, Murthy S, et al: Autologous lung-derived mesenchymal stem cell transplantation in experimental emphysema. Cell Transplant 2012;21:175-189
43. Gupta N, Su X, Popov B, et al: Intrapulmonary delivery of bone marrow- derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007;179:1855-1863
44. Mei SH, McCarter SD, Deng Y, et al: Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007;4:e269
45. Curley GF, Hayes M, Ansari B, et al: Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax 2012;67:496-501
46. Deng JC, Standiford TJ: Growth factors and cytokines in acute lung injury. Compr Physiol 2011;1:81-104
47. Chen J, Li C, Gao X, et al: Keratinocyte growth factor gene delivery via mesenchymal stem cells protects against lipopolysaccharide-induced acute lung injury in mice. PLoS One 2013;8:e83303
48. Hu S, Li J, Xu X, et al: The hepatocyte growth factor-expressing character is required for mesenchymal stem cells to protect the lung injured by lipopolysaccharide in vivo. Stem Cell Res Ther 2016;7:66
49. Thickett DR, Armstrong L, Christie SJ, et al: Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164:1601-1605
50. Yang Y, Hu S, Xu X, et al: The vascular endothelial growth factorsexpressing character of mesenchymal stem cells plays a positive role in treatment of acute lung injury in vivo. Mediators Inflamm 2016;2016:2347938
51. Koide N, Odkhuu E, Naiki Y, et al: Augmentation of LPS-induced vascular endothelial cell growth factor production in macrophages by transforming growth factor-β1. Innate Immun 2014;20:816-825